← FDA Drug Approvals (Drugs@FDA)

COXANTO

NDA · New Drug Application · Sponsor: SOLUBIOMIX · Approved 2023-10-20

Drug application

FDA Application #

NDA217927

Application type

New Drug Application

Brand name

COXANTO

Generic name

OXAPROZIN

Active ingredients

OXAPROZIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

SOLUBIOMIX

Manufacturer

SOLA Pharmaceuticals, LLC

First approval

2023-10-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown